Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases

CNS Drugs(2022)10.1007/s40263-022-00975-5Source: DataRank Database

Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases is a research paper published in CNS Drugs (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.18)OA: hybridTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Adrienne Boire ORCID,Jessica Wilcox ORCID

Live enrichment

PubMed:36474108 PMC:PMC9829628 OpenAlex:https://openalex.org/W4310958170

National Institutes of Health

Grant: P30 CA008748

National Institutes of Health

Grant: 5R01CA245499

NCI NIH HHS

Grant: R01 CA245499

National Institutes of Health

Grant: 5R01CA245499-05

Investigating Microenvironmental Interactions in Leptomeningeal Metastasis

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

FWCI

2.18

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://link.springer.com/content/pdf/10.1007/s40263-022-00975-5.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s40263-022-00975-5.pdf

publisherhttps://link.springer.com/article/10.1007/s40263-022-00975-5/fulltext.html

journalhttps://doi.org/10.1007/s40263-022-00975-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36474108

Fields of Study

Brain Metastases and TreatmentLung Cancer Treatments and MutationsLung Cancer Research Studies03 medical and health sciences0302 clinical medicineHumansRetrospective StudiesImmune Checkpoint InhibitorsProspective StudiesMeningeal CarcinomatosisBlood-Brain Barrier

MeSH Terms

Immune Checkpoint InhibitorsBlood-Brain BarrierHumansProspective StudiesRetrospective StudiesMeningeal Carcinomatosis

Keywords

MedicinePsychopharmacologyImmune systemNeurologyNeuroscienceImmunologyPsychologyPharmacologyPsychiatryBlood-Brain BarrierHumansReview ArticleProspective StudiesImmune Checkpoint InhibitorsMeningeal CarcinomatosisRetrospective Studies

Sustainable Development Goals

SDG 0: Good health and well-being